PlainRecalls
FDA Drug Low Class III Terminated

Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07.

Reported: April 13, 2022 Initiated: March 10, 2022 #D-0762-2022

Product Description

Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07.

Reason for Recall

FAILED CONTENT UNIFORMITY SPECIFICATIONS

Details

Recalling Firm
Macleods Pharma Usa Inc
Units Affected
4872 bottles
Distribution
USA Nationwide
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07.. Recalled by Macleods Pharma Usa Inc. Units affected: 4872 bottles.
Why was this product recalled?
FAILED CONTENT UNIFORMITY SPECIFICATIONS
Which agency issued this recall?
This recall was issued by the FDA Drug on April 13, 2022. Severity: Low. Recall number: D-0762-2022.